Sodium salicylate potentiates neurohumoral responses to insulin-induced hypoglycemia.
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D004837:Epinephrine / Q000097:blood*; D005934:Glucagon / Q000097:blood*; D006801:Humans; D007003:Hypoglycemia / Q000097:blood* / Q000139:chemically induced; D007328:Insulin; D007700:Kinetics; D008297:Male; D009638:Norepinephrine / Q000097:blood*; D011458:Prostaglandins E / Q000037:antagonists & inhibitors; D012980:Sodium Salicylate / Q000494:pharmacology; D013546:Sweating / Q000187:drug effects
D001786:Blood Glucose; D007328:Insulin; D011458:Prostaglandins E; D005934:Glucagon; D012980:Sodium Salicylate; D009638:Norepinephrine; D004837:Epinephrine